Bloc Operatoire Cardiaque | Delynov Cardiaque

Bloc Operatoire Cardiaque

Barlow's Disease: Alfieri Technique Matches Neochords and Reduces Clamping Time

Delynov Chirurgie, Delynov

Barlow's Disease: Alfieri Technique Matches Neochords and Reduces Clamping Time

Surgical management of Barlow's disease remains a major technical challenge due to anatomical heterogeneity: tissue excess, bileaflet prolapse, and dilata...

May 15, 2026

Thoracoscopic mitral valve repair: equivalent efficacy to sternotomy at 4 years

Delynov Chirurgie, Delynov

Thoracoscopic mitral valve repair: equivalent efficacy to sternotomy at 4 years

Surgical treatment of mitral regurgitation currently requires a constant trade-off between the optimal exposure provided by median sternotomy and the benefits of c...

May 14, 2026

Mitral valve repair failure: re-repair or valve replacement?

Delynov Chirurgie, Delynov

Mitral valve repair failure: re-repair or valve replacement?

Mitral regurgitation (MR) is the second most common valvular disease in Europe, affecting approximately 10% of individuals over 75. While surgical repair...

May 14, 2026

Eosinophilic myocarditis: unmasking clinical and histological presentations

Delynov Chirurgie, Delynov

Eosinophilic myocarditis: unmasking clinical and histological presentations

Eosinophilic myocarditis (EM) is a rare inflammatory condition whose diagnosis is frequently hindered by a heterogeneous clinical presentation and the inconsistent absence...

May 13, 2026

Rigid or semi-rigid rings: what impact on atrial fibrillation?

Delynov Chirurgie, Delynov

Rigid or semi-rigid rings: what impact on atrial fibrillation?

Mitral repair has established itself as the strategy of choice for treating degenerative mitral regurgitation, with prosthetic annuloplasty being the key step to stabilise...

May 12, 2026

Mitral Valve Repair: Why Repair Remains Superior to Replacement

Delynov Chirurgie, Delynov

Mitral Valve Repair: Why Repair Remains Superior to Replacement

Mitral valve pathologies—whether degenerative, rheumatic, ischemic, or linked to functional ventricular remodeling—constitute a major cause of...

May 10, 2026

Mitral Chordal Agenesis: TTE Unmasks Rare Adult Dysplasia

Delynov Chirurgie, Delynov

Mitral Chordal Agenesis: TTE Unmasks Rare Adult Dysplasia

Congenital mitral valve dysplasia is a rare pathology, accounting for only 0.2 to 0.4% of congenital heart diseases. Within this heterogeneous spectrum, the absence...

May 7, 2026

Tricuspid valve: assessment of successes and failures in percutaneous therapies

Delynov Chirurgie, Delynov

Tricuspid valve: assessment of successes and failures in percutaneous therapies

Long neglected due to prohibitive surgical morbidity, tricuspid regurgitation (TR) is currently benefiting from a major surge in transcatheter technological advancements. This re...

May 1, 2026

Kay, ring or band: which choice for tricuspid annuloplasty?

Delynov Chirurgie, Delynov

Kay, ring or band: which choice for tricuspid annuloplasty?

Functional tricuspid regurgitation (FTR) remains a persistent challenge in cardiac surgery, with post-operative recurrence rates ranging from 25% to 38%. This con...

May 1, 2026

Robotic mitral valve repair: safety confirmed in patients over 80

Delynov Chirurgie, Delynov

Robotic mitral valve repair: safety confirmed in patients over 80

The rise of robotic techniques has transformed the management of mitral regurgitation (MR), offering a high-performance minimally invasive alternative to conventional surgery. ...

May 1, 2026

MVRepairAI: AI predicting mitral valve repair techniques

Delynov Chirurgie, Delynov

MVRepairAI: AI predicting mitral valve repair techniques

While the superiority of mitral valve repair over replacement is well established, its success remains intrinsically linked to the surgeon's expertise and their interpretative capacity...

May 1, 2026

Malignant mitral prolapse: effective repair despite moderate regurgitation

Delynov Chirurgie, Delynov

Malignant mitral prolapse: effective repair despite moderate regurgitation

Mitral valve prolapse (MVP) is generally considered a benign condition, yet a malignant arrhythmogenic variant places certain patients at high risk of...

May 1, 2026

3
4
5
6
7